SIRIUS REAL ESTATE LIMITED
(Incorporated in Guernsey)
Company Number: 46442
JSE Share Code: SRE
LSE (GBP) Share Code: SRE
LEI: 213800NURUF5W8QSK566
ISIN Code: GG00B1W3VF54
20 November 2024
Sirius Real Estate Limited
("Sirius Real Estate", "Sirius" or the "Company")
DEALING IN SECURITIES BY SIRIUS REAL ESTATE EMPLOYEE BENEFIT TRUST
In compliance with paragraphs 3.63 to 3.74 and 3.92 of the JSE Limited Listings Requirements, the following information regarding the dealing in securities is disclosed:
NAME OF PURCHASER | Sirius Real Estate Employee Benefit Trust ("Trust") |
COMPANY TO WHICH THE DEALING RELATES | Sirius Real Estate Limited |
TYPE AND CLASS OF SECURITIES | Ordinary shares of no par value |
NATURE OF TRANSACTIONS | Purchase of 2,500,000 shares by the Trust to enable it to satisfy awards made or to be made under the Company's share incentive schemes (On-market) |
PLACE OF TRANSACTIONS | London Stock Exchange (XLON) |
DATES OF TRANSACTIONS | 18 November 2024 (1)
19 November 2024 (2) |
DATE OF NOTIFICATION | 19 November 2024 (1 - 2) |
PRICE PER SECURITY | VWAP: £0.87471 (1) High: £0.87500 Low: £0.86900
VWAP: £0.87887 (2) High: £0.87930 Low: £0.87650
|
NUMBER OF SECURITIES TRANSACTED | 46,333 (1)
2,453,667 (2) |
TOTAL VALUE OF SECURITIES TRANSACTED | £40,527.76 (1)
£2,156,456.81 (2) |
Clearance for the above was obtained in terms of paragraph 3.66 of the JSE Limited Listings Requirements.
For further information:
Sirius Real Estate Andrew Coombs, CEO Chris Bowman CFO |
+44 (0) 20 3059 0855 |
| |
FTI Consulting (financial PR) Richard Sunderland James McEwan Ellie Sweeney |
+44 (0)20 3727 1000
|
| |
JSE Sponsor PSG Capital | |
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.